Ionis Pharmaceuticals Inc (IONS)
38.76
+0.37
(+0.96%)
USD |
NASDAQ |
Nov 01, 16:00
38.76
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Shareholders Equity (Quarterly): 263.70M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 263.70M |
March 31, 2024 | 296.52M |
December 31, 2023 | 386.69M |
September 30, 2023 | 315.46M |
June 30, 2023 | 428.30M |
March 31, 2023 | 486.57M |
December 31, 2022 | 572.89M |
September 30, 2022 | 594.36M |
June 30, 2022 | 624.73M |
March 31, 2022 | 709.57M |
December 31, 2021 | 771.74M |
September 30, 2021 | 530.54M |
June 30, 2021 | 582.67M |
March 31, 2021 | 680.56M |
December 31, 2020 | 743.28M |
September 30, 2020 | 1.383B |
June 30, 2020 | 1.377B |
March 31, 2020 | 1.360B |
December 31, 2019 | 1.471B |
September 30, 2019 | 1.336B |
June 30, 2019 | 1.269B |
March 31, 2019 | 1.208B |
December 31, 2018 | 1.048B |
September 30, 2018 | 710.55M |
June 30, 2018 | 696.26M |
Date | Value |
---|---|
March 31, 2018 | 301.39M |
December 31, 2017 | 281.01M |
September 30, 2017 | 307.97M |
June 30, 2017 | 215.57M |
March 31, 2017 | 201.81M |
December 31, 2016 | 99.56M |
September 30, 2016 | 139.64M |
June 30, 2016 | 111.21M |
March 31, 2016 | 158.16M |
December 31, 2015 | 200.79M |
September 30, 2015 | 245.41M |
June 30, 2015 | 300.32M |
March 31, 2015 | 275.85M |
December 31, 2014 | 257.78M |
September 30, 2014 | 344.77M |
June 30, 2014 | 366.86M |
March 31, 2014 | 374.10M |
December 31, 2013 | 378.39M |
September 30, 2013 | 401.45M |
June 30, 2013 | 401.08M |
March 31, 2013 | 201.09M |
December 31, 2012 | 182.77M |
September 30, 2012 | 170.28M |
June 30, 2012 | 154.31M |
March 31, 2012 | 150.87M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
263.70M
Minimum
Jun 2024
1.471B
Maximum
Dec 2019
714.70M
Average
594.36M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Biogen Inc | 16.36B |
Alnylam Pharmaceuticals Inc | 32.35M |
Biomarin Pharmaceutical Inc | 5.413B |
Rigel Pharmaceuticals Inc | -29.91M |
Apellis Pharmaceuticals Inc | 264.33M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 2.691B |
Total Liabilities (Quarterly) | 2.427B |
Debt to Equity Ratio | 4.842 |
Current Ratio | 7.608 |
Net Debt Paydown Yield | -0.27% |